FDA Lifts Clinical Hold on Aardvark Therapeutics’ ARD-101
Aardvark Therapeutics said the FDA lifted the clinical hold on ARD-101, allowing clinical development for hyperphagia in Prader-Willi Syndrome to potentially resume.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.